While restrictions for obtaining hepatitis C drugs through Medicaid programs vary state by state, restrictions eased somewhat across the country from 2014 to 2016, according to data presented at the Liver Meeting 2016.
ABOUT THIS CONFERENCE: The Liver Meeting 2016 is the 67th annual meeting of the American Association for the Study of Liver Diseases (AASLD). More than 9,500 hepatologists and hepatology health professionals will gather to exchange the latest liver diseases research, discuss treatment outcomes and review the science and practice of hepatology. Please note: TheBodyPRO.com is an independent website not associated with the meeting.
TheBodyPRO is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBodyPRO and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.